{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T07:06:08Z","timestamp":1783926368011,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62373172"],"award-info":[{"award-number":["62373172"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejmech.2026.119040","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T06:33:53Z","timestamp":1780727633000},"page":"119040","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis, and biological evaluation of a potent and selective AURKB degrader"],"prefix":"10.1016","volume":"316","author":[{"given":"Lianhua","family":"Piao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejia","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanong Daniel","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9010-1750","authenticated-orcid":false,"given":"Ren","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119040_bib1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/35048096","article-title":"Mitotic kinases as regulators of cell division and its checkpoints","volume":"2","author":"Nigg","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.119040_bib2","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1093\/emboj\/17.11.3052","article-title":"A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers","volume":"17","author":"Bischoff","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2026.119040_bib3","doi-asserted-by":"crossref","first-page":"13766","DOI":"10.1074\/jbc.272.21.13766","article-title":"Cell cycle-dependent expression and spindle pole localization of a novel human protein kinase, Aik, related to Aurora of Drosophila and yeast Ipl1","volume":"272","author":"Kimura","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.119040_bib4","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/nrm1245","article-title":"The cellular geography of aurora kinases","volume":"4","author":"Carmena","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.119040_bib5","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nrm3474","article-title":"The chromosomal passenger complex (CPC): from easy rider to the godfather of mitosis","volume":"13","author":"Carmena","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.119040_bib6","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1053\/j.seminoncol.2015.09.022","article-title":"Aurora Kinase inhibitors in oncology clinical trials: current state of the progress","volume":"42","author":"Falchook","year":"2015","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.ejmech.2026.119040_bib7","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1007\/s00432-021-03669-5","article-title":"Aurora B kinase: a potential drug target for cancer therapy","volume":"147","author":"Ahmed","year":"2021","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2026.119040_bib8","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/med.21994","article-title":"Revisiting Aurora Kinase B: a promising therapeutic target for cancer therapy","volume":"44","author":"Lakkaniga","year":"2024","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2026.119040_bib9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.canlet.2014.08.039","article-title":"Overcoming cetuximab resistance in HNSCC: the role of AURKB and DUSP proteins","volume":"354","author":"Boeckx","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2026.119040_bib10","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s10549-015-3284-8","article-title":"Aurora kinase A and B as new treatment targets in aromatase inhibitor-resistant breast cancer cells","volume":"149","author":"Hole","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ejmech.2026.119040_bib11","doi-asserted-by":"crossref","first-page":"9721","DOI":"10.7150\/thno.44342","article-title":"HI-511 overcomes melanoma drug resistance via targeting AURKB and BRAF V600E","volume":"10","author":"Chang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.ejmech.2026.119040_bib12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/1724600817753098","article-title":"High expression of Aurora-B is correlated with poor prognosis and drug resistance in non-small cell lung cancer","volume":"33","author":"Yu","year":"2018","journal-title":"Int. J. Biol. Markers"},{"key":"10.1016\/j.ejmech.2026.119040_bib13","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00109-014-1228-0","article-title":"Sequential treatment with aurora B inhibitors enhances cisplatin-mediated apoptosis via c-Myc","volume":"93","author":"Ma","year":"2015","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ejmech.2026.119040_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28083385","article-title":"Aurora B inhibitors as cancer therapeutics","volume":"28","author":"Kovacs","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119040_bib15","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1182\/blood-2007-02-073700","article-title":"AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo","volume":"110","author":"Yang","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2026.119040_bib16","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s10637-012-9825-7","article-title":"Phase I study of barasertib (AZD1152), a selective inhibitor of Aurora B kinase, in patients with advanced solid tumors","volume":"31","author":"Schwartz","year":"2013","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.ejmech.2026.119040_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13045-018-0695-0","article-title":"Phase I dose-escalation study of chiauranib, a novel angiogenic, mitotic, and chronic inflammation inhibitor, in patients with advanced solid tumors","volume":"12","author":"Sun","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ejmech.2026.119040_bib18","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/bjh.15563","article-title":"A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia","volume":"185","author":"Dohner","year":"2019","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ejmech.2026.119040_bib19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00280-016-3095-6","article-title":"A phase I study of BI 811283, an Aurora B kinase inhibitor, in patients with advanced solid tumors","volume":"78","author":"Mross","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119040_bib20","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.3109\/10428194.2015.1091927","article-title":"A phase II study of AT9283, an aurora kinase inhibitor, in patients with relapsed or refractory multiple myeloma: NCIC clinical trials group IND.191","volume":"57","author":"Hay","year":"2016","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.ejmech.2026.119040_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26351","article-title":"A phase I\/II trial of AT9283, a selective inhibitor of aurora kinase in children with relapsed or refractory acute leukemia: challenges to run early phase clinical trials for children with leukemia","volume":"64","author":"Vormoor","year":"2017","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.ejmech.2026.119040_bib22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1517\/13543784.2012.652303","article-title":"Danusertib, an aurora kinase inhibitor","volume":"21","author":"Meulenbeld","year":"2012","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.ejmech.2026.119040_bib23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1464-410X.2012.11404.x","article-title":"Randomized phase II study of danusertib in patients with metastatic castration-resistant prostate cancer after docetaxel failure","volume":"111","author":"Meulenbeld","year":"2013","journal-title":"BJU Int."},{"key":"10.1016\/j.ejmech.2026.119040_bib24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"Bekes","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119040_bib25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrd.2016.211","article-title":"Induced protein degradation: an emerging drug discovery paradigm","volume":"16","author":"Lai","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119040_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202400703","article-title":"Development of dual Aurora-A and Aurora-B degrading PROTACs for MCYN-amplified neuroblastoma","volume":"20","author":"Nelson","year":"2025","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2026.119040_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118006","article-title":"Discovery of the first-in-class Aurora B kinase selective degrader","volume":"298","author":"Hu","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119040_bib28","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1107\/S2053230X14002118","article-title":"Structure of Aurora B-INCENP in complex with barasertib reveals a potential transinhibitory mechanism","volume":"70","author":"Sessa","year":"2014","journal-title":"Acta crystallographica. Section F, Structural biology communications"},{"key":"10.1016\/j.ejmech.2026.119040_bib29","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41589-018-0055-y","article-title":"Plasticity in binding confers selectivity in ligand-induced protein degradation","volume":"14","author":"Nowak","year":"2018","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119040_bib30","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1021\/acs.jcim.9b00445","article-title":"CoDockPP: a multistage approach for global and site-specific protein-protein docking","volume":"59","author":"Kong","year":"2019","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.119040_bib31","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1021\/jm990345w","article-title":"Design and structure-activity relationship of a new class of potent VEGF receptor tyrosine kinase inhibitors","volume":"42","author":"Hennequin","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119040_bib32","doi-asserted-by":"crossref","first-page":"103172","DOI":"10.1039\/C5RA12837D","article-title":"Design, synthesis and biological evaluation of novel podophyllotoxin derivatives bearing 4\u03b2-disulfide\/trisulfide bond as cytotoxic agents","volume":"5","author":"Zhu","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2026.119040_bib33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nature13527","article-title":"Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide","volume":"512","author":"Fischer","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.119040_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26071981","article-title":"Aurora kinase B inhibition: a potential therapeutic strategy for cancer","volume":"26","author":"Borah","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119040_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113371","article-title":"Promising therapy in lung cancer: spotlight on Aurora kinases","volume":"12","author":"Galetta","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2026.119040_bib36","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejmech.2026.119040_bib37","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","article-title":"ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB","volume":"11","author":"Maier","year":"2015","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.ejmech.2026.119040_bib38","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2026.119040_bib39","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N\u22c5log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejmech.2026.119040_bib40","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0021-9991(77)90098-5","article-title":"Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes","volume":"23","author":"Ryckaert","year":"1977","journal-title":"J. Comput. Phys."},{"key":"10.1016\/j.ejmech.2026.119040_bib41","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/ct300418h","article-title":"MMPBSA.py: an efficient Program for end-state free energy calculations","volume":"8","author":"Miller","year":"2012","journal-title":"J. Chem. Theor. Comput."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342600485X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342600485X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:18:35Z","timestamp":1783923515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342600485X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":41,"alternative-id":["S022352342600485X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119040","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and biological evaluation of a potent and selective AURKB degrader","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119040"}}